Bacterial superantigens

Clinical and Experimental Immunology

Volumn 133, Issue 3, 2003, Pages 299-306

  Proft, T ^a   Fraser, John D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Enterotoxin; MHC; Superantigen; TcR; Toxic shock

Indexed keywords

BACTERIAL ANTIGEN; ENTEROTOXIN; HLA DR1 ANTIGEN; HLA DR2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; BINDING SITE; DEATH; DISEASE ASSOCIATION; FEVER; FOOD POISONING; MOUSE MAMMARY TUMOR ONCOVIRUS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

ANIMALS; AUTOIMMUNE DISEASES; BINDING SITES; DISEASE SUSCEPTIBILITY; ENTEROTOXINS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MAMMARY TUMOR VIRUS, MOUSE; MICE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECEPTORS, ANTIGEN, T-CELL; RHEUMATIC FEVER; SHOCK, SEPTIC; STAPHYLOCOCCAL FOOD POISONING; STAPHYLOCOCCUS; STREPTOCOCCUS; SUPERANTIGENS;

EID: 0041358919     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02203.x     Document Type: Review

References (75)

1. Bohach G, Fast D, Nelson R et al. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17:251-72.
2. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248:705-11.
3. Miethke T, Wahl C, Heeg K et al. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B. Critical role of tumor necrosis factor. J Exp Med 1992; 175:91-8.
4. Dellabona P, Peccoud J, Kappler J et al. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 1990; 62:1115-21.
5. Herman A, Kappler J, Marrack P et al. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 1991; 9:745-72.
6. Seth A, Stern L, Ottenhoff T et al. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 1994; 369:324-7.
7. Fast D, Schlievert P, Nelson R. Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun 1989; 57:291-4.
8. Jupin C, Anderson S, Damais C et al. Toxic shock syndrome toxin as an inducer of human tumor necrosis factors and γ-interferon. J Exp Medical 1988:167.
9. Baba T, Takeuchi F, Kuroda M et al. Genome and virulence determinants of high virulence community-aquired MRSA. Lancet 2002; 359:1819-27.
10. Beres S, Sylva G, Barbian K et al. Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci USA 2002; 99:10078-83.
11. Ferretti J, Mcshan W, Ajdic D et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 2001; 98:4658-63.
12. Proft T, Moffatt S, Berkahn C et al. Identification and characterization of novel superantigens from Streptococcus pyogenes. J Exp Med 1999; 189:89-101.
13. Smoot J, Barbian K, Van Gompel J et al. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA 2002; 99:4668-73.
14. Kuroda M, Ohta T, Uchiyama I et al. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001; 357:1225-40.
15. Thibodeau J, Cloutier I, Lavoie P et al. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science 1994; 266:1874-8.
16. Herman A, Croteau G, Sekaly RP et al. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med 1990; 172:709-17.
17. Norrby-Teglund A, Nepom G, Kotb M. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles. Eur J Immunol 2002; 32:2570-7.
18. Bonventre P, Heeg H, Cullen C et al. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in rabbit infection model of toxic shock syndrome. Infect Immun 1993; 61:793-9.
19. Ikebe T, Wada A, Inagaki Y et al. Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan. Infect Immun 2002; 70:3227-33.
20. Proft T, Webb P, Handley V et al. Two novel superantigens found in both Group A and Group C Streptococcus. Infect Immun 2003; 71(3):1361-9.
21. Artiushin S, Timoney J, Sheoran A et al. Characterization and immunogenicity of pyrogenic mitogens SePE-H and SePE-I of Streptococcus equi. Microb Pathol 2002; 32:71-85.
22. Miyoshi-Akiyama T, Zhao J, Kato H et al. Streptococcus dysgalactiae-derived mitogen (SDM), a novel bacterial superantigen: characterization of its biological activity and predicted tertiary structure. Mol Microbiol 2003; 47:1589-99.
23. Sachse S, Seidel P, Gerlach D et al. Superantigen-like gene (s) in human pathogenic Streptococcus dysgalactiae, subsp equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG (dys). FEMS Immunol Med Microbiol 2002; 34:159-67.
24. Ito Y, Abe J, Yoshino K et al. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein. J Immunol 1995; 154:5896-906.
25. Cole B, Atkin C. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol Today 1991; 12:271-6.
26. Alvarezossorio L, Johannsen M, Alvarezossorio R et al. Cytokine induction by Mycoplasma arthritidis-derived superantigen (Mas), but not by Tsst-1 or Sec-3, is correlated to certain HLA-DR types. Scand J Immunol 1998; 47:43-7.
27. Hodtsev A, Choi Y, Spanopoulou E et al. Mycoplasma superantigen is a Cdr3-dependent ligand for the T cell antigen receptor. J Exp Med 1998; 187:319-27.
28. Acharya K, Passalacqua E, Jones E et al. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin 1. Nature 1994; 367:94-7.
29. Arcus V, Proft T, Sigrell J et al. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes. J Mol Biol 2000; 299:157-68.
30. Papageorgiou A, Acharya K, Shapiro R et al. Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure 1995; 3:769-79.
31. Hakansson M, Petersson K, Nilsson H et al. The crystal structure of staphylococcal enterotoxin H. Implications for binding properties to MHC class II and TcR molecules. J Mol Biol 2000; 302:527-37.
32. Roussel A, Anderson B, Baker H et al. Crystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules. Nature Struct Biol 1997; 4:635-43.
33. Schad E, Zaitseva I, Zaitsev V et al. Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J 1995; 14:3292-301.
34. Sundstrom M, Abrahmsen L, Antonsson P et al. The crystal structure of staphylococcal enterotoxin type D reveals Zn2+-mediated homodimerization. EMBO J 1996; 15:6832-40.
35. Swaminathan S, Furey W, Pletcher J et al. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 1992; 359:801-6.
36. Jardetzky T, Brown J, Gorga J et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 1994; 368:711-8.
37. Kim J, Urban R, Strominger J et al. Toxic shock syndrome toxin 1 complexed with a class II major histocompatibility molecule HLA-DR1. Science 1994; 266:1870-4.
38. Hudson K, Tiedemann R, Urban R et al. Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J Exp Med 1995; 182:711-20.
39. Kozono H, Parker D, White J et al. Multiple binding sites for bacterial superantigens on soluble class II MHC molecules. Immunity 1995; 3:187-96.
40. Mehindate K, Thibodeau J, Dohlsten M et al. Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression. J Exp Med 1995; 182:1573-7.
41. Tiedemann R, Fraser J. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation. J Immunol 1996; 157:3958-66.
42. Li Y, Li H, Dimasi N et al. Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC Class II. Immunity 2001; 14:93-104.
43. Petersson K, Hakansson M, Nilsson H et al. Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence. EMBO J 2001; 20:3306-12.
44. Hogan R, Van Beek J, Broussard D et al. Identification of MHC Class II-associated peptides that promote the presentation of toxic shock syndrome toxin 1 to T cells. J Immunol 2001; 166:6514-22.
45. Wen R, Cole G, Surman S et al. Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J Exp Med 1996; 183:1083-92.
46. Li P, Tiedemann R, Moffat S et al. The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action. J Exp Med 1997; 186:375-83.
47. Fields B, Malchiodi E, Li H et al. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature 1996; 384:188-92.
48. Leder L, Llera A, Lavoie P et al. A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor b chain and major histocompatibility complex Class II. J Exp Med 1998; 187:823-33.
49. Li H, Llera A, Tsuchiya D et al. Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity 1998; 9:807-16.
50. Sundberg E, Li H, Llera A et al. Structures of two streptococcal superantigens bound to TCR β chains reveal diversity in the architecture of T cell signalling complex. Structure 2002; 10:687-99.
51. Williams R, Ward J, Henderson B et al. Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins. Characterization of the prototypic gene and its protein product, SET1. Infect Immun 2000; 68:4407-15.
52. Arcus V, Langley R, Proft T et al. The three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome. J Biol Chem 2002; 277:32274-81.
53. Felsenstein H, Kimura S. The Mls system: past and present. J Immunogenet 1988; 15:183-96.
54. Acha-Orbea H, MacDonald H. Superantigens of mouse mammary tumor virus. Annu Rev Immunol 1995; 13:459-86.
55. Sutkowski N, Palkama T, Ciurli C et al. An Epstein-Barr virus-associated superantigen. J Exp Med 1996; 184:971-80.
56. Sutkowski N, Conrad B, Thorley-Lawson D et al. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001; 15:579-89.
57. Stauffer Y, Marguerat S, Meylan F et al. Interferon-alpha-induced endogenous superantigen: a model linking environment and autoimmunity. Immunity 2001; 15:591-601.
58. Conrad B, Weissmahr R, Boni J et al. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997; 90:303-13.
59. Alber G, Hammer D, Fleischer B. Relationship between enterotoxic- and T lymphocyte-stimulating activity of staphylococcal enterotoxin B. J Immunol 1990; 144:4501-6.
60. McCormick J, Yarwood J, Schlievert P. Toxic shock syndrome and bacterial superantigens. An update. Annu Rev Microbiol 2001; 55:77-104.
61. Dinges M, Orwin P, Schlievert P. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13:16-34.
62. Stevens D. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14:2-13.
63. Stevens D. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med 2000; 51:271-88.
64. Yu C, Ferretti J. Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. Infect Immun 1989; 57:3715-9.
65. Musser J, Hauser A, Kim M et al. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 1991; 88:2668-72.
66. Basma H, Norrby-Teglund A, Guedez Y et al. Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun 1999; 67:1871-7.
67. Eriksson B, Andersson J, Holm S et al. Invasive Group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 1999; 180:410-8.
68. Sriskandan S, Moyes D, Cohen J. Detection of circulating bacterial superantigen and lymphotoxin-a in patients with streptococcal toxic shock syndrome. Lancet 1996; 348:1315-6.
69. Smoot L, McCormick J, Smoot J et al. Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect Immun 2002; 70:7095-104.
70. Abe J, Kotzin B, Jujo K et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci USA 1992; 89:4066-70.
71. Leung D, Meissner C, Fulton D et al. The potential role of bacterial superantigens in the pathogenesis of Kawasaki syndrome. J Clin Immunol 1995; 15:11S-7S.
72. Konishi N, Baba K, Abe J et al. A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection. Acta Paediatr 1996; 86:661-4.
73. Racke M, Quigley L, Cannella B et al. Superantigen modulation of experimental allergic encephalomyelitis: activation of anergy determines outcome. J Immunol 1994; 152:2051-9.
74. Schiffenbauer J, Johnson H, Butfiloski E et al. Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Ac Sci USA 1993; 90:8543-6.
75. Kotb M, Norrby-Teglund A, McGeer A et al. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nature Med 2002; 8:1398-404.